Innoviva
INVA
198 hedge funds and large institutions have $1.2B invested in Innoviva in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 67 increasing their positions, 71 reducing their positions, and 24 closing their positions.
895% more call options, than puts
Call options by funds: $1.87M | Put options by funds: $188K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
34% more capital invested
Capital invested by funds: $892M → $1.2B (+$306M)
21% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 24
11.61% more ownership
Funds ownership: 104.93% → 116.54% (+12%)
3% more funds holding
Funds holding: 193 → 198 (+5)
6% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 71
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$47.5M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$24.2M |
| 3 |
BlackRock
New York
|
+$12.7M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$7.96M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$9.62M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$5.92M |
| 3 |
Millennium Management
New York
|
-$4.87M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.76M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$2.63M |
INVA Hedge Fund Activity: Q4 2023 in Review
198 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2023, worth a combined $1.2B — up 34% from $892M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new INVA positions and 24 closed out — a net gain of 5 holders — while 67 added to existing stakes and 71 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $47.5M. The largest seller was American Century Companies, cutting an estimated $9.62M.
- 198 institutional investors held Innoviva (INVA) as of Q4 2023, up from 193 in Q3 2023.
- Funds reported $1.2B of Innoviva stock for Q4 2023, up 34% quarter-over-quarter.
- 29 funds opened new Innoviva positions in Q4 2023 and 24 closed out, a net change of +5 holders.
- The largest Innoviva buyer in Q4 2023 was Morgan Stanley, an estimated $47.5M added.
- The largest Innoviva seller in Q4 2023 was American Century Companies, an estimated $9.62M sold.
Based on aggregated 13F filings for Q4 2023.